Poster SESSIONS
73
Poster, 25 June 2014
Authors are asked to present their posters during the poster sessions.
P-42-022
Vortioxetine treatment reverses cognitive
impairment induced by long-term dysregula-
tion of glutamate neurotransmission in rats
Alan Pehrson, Paramus, USA
J. Waller, N. Plath, C. Sanchez
P-42-023
Synaptic and neuroplastic mechanisms of
chronic lurasidone treatment in the chronic
mild stress model
Marco Andrea Riva, Milan, Italy
F. Macchi, A. C. Rossetti, M. Papp, R. Molteni
P-42-024
Neurobiological correlates of anhedonia:
Findings based on the dimensional anhe-
donia rating scale
Sakina Rizvi, Toronto, Canada
A. Cyriac, A. Strafella, B. Sproule, S. Kennedy
P-42-025
Clinical depression predicts paranoia in high-
risk patients
Raimo K. R. Salokangas, Turku, Finland
T. From, M. Heinimaa, J. Hietala, H. Graf von
Reventlow, D. Linszen, P. Dingemans, M. Birch-
wood, P. Patterson, S. Ruhrmann, J. Klosterkötter
P-42-026
Vortioxetine, a multimodal-acting antidepres-
sant with distinct pharmacological properties–
a comparative preclinical study vs. SRIs
Connie Sanchez, Paramus, USA
E. Dale, Y. Li, S. C. Leiser, M. Gulinello
P-42-027
Cognitive impairment in depression
Edith Serfaty, Buenos Aires, Argentina
S. M. Zanone
P-42-028
Having difficulty concentrating or making de-
cisions is a useful clinical cue for depression
Noam Ship, Toronto, Canada
A. Thompson
P-42-029
Resilience and vulnerability are dose-de-
pendently related to corticosterone treat-
ment in adult but not adolescent rats
Tianmei Si, Beijing, China
Y. Li, J. Li, X. Liao, Y. Zhao, Y. Su
P-42-030
Alterations of the cortisol and dehydroepian-
drosterone (DHEA) in perinatal depression
Ho-Suk Suh, Seoul, Republic of Korea
R.-S. Ahn, K.-S. Lee, C.-H. Kim
P-42-031
A clinical case of velaxin therapy in a teenager
Elena Valzdorf, Irkutsk, Russia
P-42-032
The cognitive effects of vortioxetine are as-
sociated with increased expression of neu-
roplasticity markers
Jessica Waller, Paramus, USA
P-42-033
Randomised, double-blind study of vortiox-
etine versus venlafaxine in adults with major
depressive disorder (MDD)
Gang Wang, Beijing, China
M. Gislum, G. Filippov
P-42-034
Effects of levomilnacipran er on measures
of attention in a phase III trial of major de-
pressive disorder
Keith Wesnes, Reading, United Kingdom
C. Gommoll, C. Chen
P-42-035
An international study of the grid-hamd:
Has it fulfilled its promise?
Janet Williams, Hamilton, USA
M. Ondrus, M. K. Rishton, J. Persson, M. Po-
pescu, R. Valjakka
P-42-036
Correlation analysis of hair cortisol levels in
female depressions
Xiao Yang, Chengdu, China
X. Ma
P-42-037
Herbal medicine for hospitalized patients
with severe depressive episode: A non-ran-
domized controlled study
Zhang-Jin Zhang, Hong Kong SAR, China
L.-Y. Liu, B. Feng, J. Chen
